Risk of serotonin syndrome in patients prescribed triptans for migraine with antidepressants seem to be low, which may suggest an advisory from the U.S. Food and Administration on that risk should be reconsidered.
from Medindia Health News http://ift.tt/2F2MBk4
No comments:
Post a Comment